Steris (STE) Receivables - Other (2019 - 2020)

Steris' (STE) quarterly Receivables - Other came in at $9.0 million in Q4 2020, up 4.93% quarter-over-quarter from $8.5 million in Q3 2020.

Steris (STE) Receivables - Other (2019 - 2020) Analysis & Trends

Steris' Receivables - Other history runs 2 years deep, the most recent figure standing at $9.0 million for Q4 2020.

On a quarterly basis, Receivables - Other changed N/A year-over-year to $9.0 million in Q4 2020; TTM through Dec 2020 was $9.0 million, a N/A change from a year earlier, with the FY2020 full-year figure at $8.1 million, down 4.97% from the prior year.
Receivables - Other climbed to $9.0 million in Q4 2020 per STE's latest filing, from $8.5 million in the prior quarter.
Across five years, Receivables - Other topped out at $9.0 million in Q4 2020 and bottomed at $8.1 million in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Steris	20.59 Bn	20.16 Bn	697.10 Mn

Download Data